What to Tell a Prescriber Useful detail: when it started relative to starting the medication or changing dosage, whether it follows the injection in a pattern, what else changed at the same time, whether you are eating and drinking normally, and what other medications and supplements you take
Clinical data shows weight regain of 20-50% of lost weight within months after cold-turkey cessation
FTO (rs9939609) Metabolic set point: The FTO rs9939609 A allele is associated with a higher caloric set point and reduced satiety signaling efficiency
It is a coping strategy that served you for years
If you experience bothersome side effects, your provider may modify your dose increase or adjust your overall treatment approach
As part of the prior authorization process for Bridge, prescribing clinicians will need to attest that the GLP-1 prescription is for weight reduction and weight management and that beneficiaries meet the clinical criteria and do not have a diagnosis of type 2 diabetes, OSA, or MASH that would make them eligible for GLP-1 coverage under Part D